Speciality: Oncology
Description:
Welcome to this insightful discussion featuring Dr. Vamshi Krishna M, a renowned expert in oncology, as he delves into the unmet needs and challenges in the current care of ALK-positive Non-Small Cell Lung Cancer (NSCLC). In this video, Dr. Vamshi highlights the significant gaps in treatment options, including resistance mechanisms, limited access to next-generation therapies, and the need for personalized approaches to improve patient outcomes. He emphasizes the importance of early detection, advanced diagnostics, and the development of novel therapeutic strategies to address these pressing issues.
Dr. Vamshi further explores the real-world challenges faced by clinicians managing ALK-positive NSCLC, such as treatment sequencing, managing side effects, and optimizing therapy for better survival rates. He discusses the evolving landscape of targeted therapies and immunotherapy while underscoring the necessity for more clinical trials and collaborative research to bridge existing gaps. His expertise provides valuable perspectives for oncologists, researchers, and healthcare professionals striving to enhance patient care in this niche yet critical area of lung cancer.
Don’t miss this compelling discussion that sheds light on the future directions and unmet needs in ALK-positive NSCLC. Stay tuned for more expert insights from Dr. Vamshi Krishna M and other leading voices in oncology. Be sure to watch till the end and subscribe for updates on upcoming videos that continue to explore groundbreaking advancements in cancer care.
See More Webinars @ Hidoc Webinars
1.
Study sets benchmark for treatment of advanced cervical cancer
2.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
3.
Children with rare gliomas have new hope thanks to clinical trial results.
4.
Cancer Treatment Ups CV Risk; Therapy's Next Big Thing; Nude Photos Settlement
5.
For fit patients with CLL, frontline venetoclax-ibrutinib improves survival.
1.
CAR T-Cell Therapy: Revolutionizing Hematologic Malignancies
2.
Beyond the Organs: Navigating the Era of Tissue-Agnostic Therapies in Modern Cancer Management
3.
How AI is Transforming Diagnostics, Drug Discovery, and Personalized Oncology
4.
All You Need To Know About Cancer Antigen 27-29: Causes, Symptoms & Treatment
5.
Cardiotoxicity Beyond Anthracyclines: Redefining Risk in the Cardio-Oncology Era
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
3.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation